| pubmed-article:1653942 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1653942 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
| pubmed-article:1653942 | lifeskim:mentions | umls-concept:C0597694 | lld:lifeskim |
| pubmed-article:1653942 | lifeskim:mentions | umls-concept:C0035696 | lld:lifeskim |
| pubmed-article:1653942 | lifeskim:mentions | umls-concept:C2936401 | lld:lifeskim |
| pubmed-article:1653942 | lifeskim:mentions | umls-concept:C0205245 | lld:lifeskim |
| pubmed-article:1653942 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:1653942 | lifeskim:mentions | umls-concept:C1720154 | lld:lifeskim |
| pubmed-article:1653942 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:1653942 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:1653942 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:1653942 | pubmed:dateCreated | 1991-10-17 | lld:pubmed |
| pubmed-article:1653942 | pubmed:abstractText | Xenopus oocytes injected with embryonic guinea-pig brain mRNA expressed functional P2Y purinoceptors. Extracellular ATP stimulated in a dose-dependent manner a delayed Ca(2+)-dependent Cl- current component. Analysis of the interactions of ATP with compounds that affect Ca2+ fluxes through the plasma membrane or Ca2+ release from internal stores indicates that ATP raises [Ca2+]i by a mechanism that involves activation of voltage-dependent Ca2+ channels, which leads to influx of extracellular Ca2+ into the cells, as well as release of Ca2+ from intracellular stores. Since this phenomenon was not found in control oocytes, it is suggested that brain mRNA encoded for a newly synthesized Ca(2+)-release process stimulated by purinoceptor activation. This mechanism could be largely involved in the short-term regulation of intracellular Ca2+ level involved in ATP neuromodulation functions. | lld:pubmed |
| pubmed-article:1653942 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1653942 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1653942 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1653942 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1653942 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1653942 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1653942 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1653942 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1653942 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1653942 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1653942 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:1653942 | pubmed:issn | 0031-6768 | lld:pubmed |
| pubmed-article:1653942 | pubmed:author | pubmed-author:NargeotJJ | lld:pubmed |
| pubmed-article:1653942 | pubmed:author | pubmed-author:FournierFF | lld:pubmed |
| pubmed-article:1653942 | pubmed:author | pubmed-author:HonoréEE | lld:pubmed |
| pubmed-article:1653942 | pubmed:author | pubmed-author:GuilbaultPP | lld:pubmed |
| pubmed-article:1653942 | pubmed:author | pubmed-author:CollisSS | lld:pubmed |
| pubmed-article:1653942 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1653942 | pubmed:volume | 418 | lld:pubmed |
| pubmed-article:1653942 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1653942 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1653942 | pubmed:pagination | 447-52 | lld:pubmed |
| pubmed-article:1653942 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1653942 | pubmed:meshHeading | pubmed-meshheading:1653942-... | lld:pubmed |
| pubmed-article:1653942 | pubmed:meshHeading | pubmed-meshheading:1653942-... | lld:pubmed |
| pubmed-article:1653942 | pubmed:meshHeading | pubmed-meshheading:1653942-... | lld:pubmed |
| pubmed-article:1653942 | pubmed:meshHeading | pubmed-meshheading:1653942-... | lld:pubmed |
| pubmed-article:1653942 | pubmed:meshHeading | pubmed-meshheading:1653942-... | lld:pubmed |
| pubmed-article:1653942 | pubmed:meshHeading | pubmed-meshheading:1653942-... | lld:pubmed |
| pubmed-article:1653942 | pubmed:meshHeading | pubmed-meshheading:1653942-... | lld:pubmed |
| pubmed-article:1653942 | pubmed:meshHeading | pubmed-meshheading:1653942-... | lld:pubmed |
| pubmed-article:1653942 | pubmed:meshHeading | pubmed-meshheading:1653942-... | lld:pubmed |
| pubmed-article:1653942 | pubmed:meshHeading | pubmed-meshheading:1653942-... | lld:pubmed |
| pubmed-article:1653942 | pubmed:meshHeading | pubmed-meshheading:1653942-... | lld:pubmed |
| pubmed-article:1653942 | pubmed:meshHeading | pubmed-meshheading:1653942-... | lld:pubmed |
| pubmed-article:1653942 | pubmed:meshHeading | pubmed-meshheading:1653942-... | lld:pubmed |
| pubmed-article:1653942 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1653942 | pubmed:articleTitle | Functional expression of P2Y purinoceptor in Xenopus oocyte injected with brain mRNA. | lld:pubmed |
| pubmed-article:1653942 | pubmed:affiliation | Laboratorie de Physiologie Cellulaire UFR de Biologie, Université des Sciences et Techniques de Lille-Flandres-Artois, Villeneuve d'Ascq, France. | lld:pubmed |
| pubmed-article:1653942 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1653942 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
